 Lisa Cicutto
Concepts (303)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| School Health Services | 16 | 2024 | 238 | 5.110 |
Why?
| | Asthma | 56 | 2024 | 2295 | 4.760 |
Why?
| | School Nursing | 3 | 2018 | 32 | 1.540 |
Why?
| | Patient Education as Topic | 14 | 2015 | 766 | 1.140 |
Why?
| | Needs Assessment | 4 | 2024 | 376 | 1.010 |
Why?
| | Ontario | 20 | 2011 | 148 | 0.930 |
Why?
| | Nurses, Public Health | 2 | 2014 | 5 | 0.880 |
Why?
| | Disease Management | 6 | 2018 | 628 | 0.870 |
Why?
| | Evidence-Based Practice | 3 | 2016 | 229 | 0.830 |
Why?
| | Community Health Services | 5 | 2018 | 227 | 0.780 |
Why?
| | Program Development | 5 | 2018 | 364 | 0.720 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 5 | 2018 | 1040 | 0.680 |
Why?
| | Social Determinants of Health | 1 | 2024 | 267 | 0.650 |
Why?
| | Schools | 9 | 2022 | 461 | 0.610 |
Why?
| | Colorado | 9 | 2024 | 4565 | 0.570 |
Why?
| | Self Care | 6 | 2016 | 380 | 0.570 |
Why?
| | Child | 33 | 2024 | 21935 | 0.560 |
Why?
| | Competency-Based Education | 1 | 2016 | 73 | 0.500 |
Why?
| | Particulate Matter | 1 | 2018 | 315 | 0.480 |
Why?
| | Respiratory Therapy | 1 | 2015 | 23 | 0.470 |
Why?
| | Frailty | 1 | 2018 | 170 | 0.470 |
Why?
| | Nurse's Role | 1 | 2016 | 161 | 0.450 |
Why?
| | Primary Health Care | 6 | 2014 | 1738 | 0.440 |
Why?
| | Ambulatory Care | 1 | 2018 | 546 | 0.430 |
Why?
| | Attitude to Health | 4 | 2007 | 439 | 0.430 |
Why?
| | Practice Guidelines as Topic | 7 | 2016 | 1587 | 0.420 |
Why?
| | Humans | 74 | 2024 | 137585 | 0.410 |
Why?
| | Anaphylaxis | 2 | 2011 | 105 | 0.400 |
Why?
| | Health Personnel | 3 | 2016 | 710 | 0.400 |
Why?
| | Rural Health Services | 1 | 2014 | 128 | 0.390 |
Why?
| | Emergency Service, Hospital | 5 | 2018 | 2069 | 0.380 |
Why?
| | Medical Records | 4 | 2009 | 177 | 0.370 |
Why?
| | Quality Assurance, Health Care | 1 | 2014 | 322 | 0.360 |
Why?
| | Health Services Accessibility | 5 | 2024 | 986 | 0.350 |
Why?
| | Hospitalization | 3 | 2018 | 2199 | 0.330 |
Why?
| | Occupational Diseases | 1 | 2011 | 156 | 0.320 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2015 | 1329 | 0.310 |
Why?
| | Child Care | 1 | 2009 | 32 | 0.310 |
Why?
| | Adolescent | 20 | 2024 | 21513 | 0.300 |
Why?
| | Bronchodilator Agents | 5 | 2021 | 252 | 0.300 |
Why?
| | Female | 38 | 2024 | 73304 | 0.300 |
Why?
| | Cost of Illness | 2 | 2008 | 308 | 0.290 |
Why?
| | Plagiarism | 1 | 2008 | 3 | 0.290 |
Why?
| | Population Surveillance | 1 | 2011 | 482 | 0.280 |
Why?
| | Hotlines | 1 | 2007 | 32 | 0.280 |
Why?
| | Child, Preschool | 13 | 2024 | 11074 | 0.280 |
Why?
| | Male | 36 | 2024 | 67762 | 0.270 |
Why?
| | Observer Variation | 1 | 2008 | 343 | 0.270 |
Why?
| | Public Health Nursing | 1 | 2006 | 6 | 0.260 |
Why?
| | Education, Medical, Continuing | 2 | 2005 | 127 | 0.260 |
Why?
| | Disease Progression | 3 | 2018 | 2757 | 0.260 |
Why?
| | Documentation | 1 | 2008 | 194 | 0.250 |
Why?
| | Public Health Practice | 1 | 2006 | 70 | 0.240 |
Why?
| | Anti-Asthmatic Agents | 7 | 2009 | 395 | 0.240 |
Why?
| | Program Evaluation | 4 | 2018 | 898 | 0.240 |
Why?
| | Education, Professional | 1 | 2005 | 17 | 0.240 |
Why?
| | Guidelines as Topic | 2 | 2021 | 275 | 0.230 |
Why?
| | Lung Transplantation | 2 | 2007 | 313 | 0.230 |
Why?
| | Certification | 1 | 2005 | 113 | 0.220 |
Why?
| | Specialization | 1 | 2005 | 144 | 0.220 |
Why?
| | Recurrence | 1 | 2007 | 1060 | 0.220 |
Why?
| | Health Care Costs | 1 | 2008 | 398 | 0.220 |
Why?
| | Adult | 27 | 2018 | 37929 | 0.220 |
Why?
| | Clinical Competence | 2 | 2016 | 1118 | 0.210 |
Why?
| | Pilot Projects | 3 | 2024 | 1710 | 0.210 |
Why?
| | Respiratory Sounds | 1 | 2024 | 125 | 0.210 |
Why?
| | Breath Tests | 1 | 2004 | 87 | 0.210 |
Why?
| | Quality of Life | 5 | 2013 | 2892 | 0.200 |
Why?
| | Registries | 1 | 2011 | 2035 | 0.200 |
Why?
| | Vulnerable Populations | 1 | 2024 | 163 | 0.200 |
Why?
| | Biomedical Research | 2 | 2023 | 692 | 0.200 |
Why?
| | Delphi Technique | 1 | 2024 | 280 | 0.190 |
Why?
| | Awards and Prizes | 1 | 2023 | 67 | 0.190 |
Why?
| | Depression | 1 | 2011 | 1397 | 0.190 |
Why?
| | Nebulizers and Vaporizers | 2 | 2015 | 86 | 0.190 |
Why?
| | Employment | 1 | 2004 | 178 | 0.190 |
Why?
| | Angioplasty, Balloon | 1 | 2023 | 93 | 0.190 |
Why?
| | Social Support | 4 | 2011 | 618 | 0.190 |
Why?
| | Organizational Case Studies | 2 | 2016 | 78 | 0.190 |
Why?
| | Sputum | 1 | 2004 | 311 | 0.180 |
Why?
| | Monitoring, Physiologic | 1 | 2004 | 275 | 0.180 |
Why?
| | Attitude of Health Personnel | 2 | 2009 | 1171 | 0.180 |
Why?
| | Parents | 3 | 2024 | 1347 | 0.180 |
Why?
| | Albuterol | 1 | 2021 | 110 | 0.180 |
Why?
| | Health Services | 3 | 2013 | 107 | 0.170 |
Why?
| | Surveys and Questionnaires | 11 | 2015 | 5778 | 0.170 |
Why?
| | Bronchial Neoplasms | 1 | 2000 | 15 | 0.170 |
Why?
| | Adaptation, Psychological | 2 | 2010 | 655 | 0.170 |
Why?
| | Carcinoma, Mucoepidermoid | 1 | 2000 | 16 | 0.170 |
Why?
| | Lung Diseases | 2 | 2022 | 767 | 0.170 |
Why?
| | Health Equity | 1 | 2022 | 99 | 0.170 |
Why?
| | Societies, Medical | 1 | 2024 | 820 | 0.160 |
Why?
| | Family | 3 | 2018 | 671 | 0.160 |
Why?
| | Absenteeism | 3 | 2018 | 49 | 0.160 |
Why?
| | Connecticut | 1 | 2018 | 27 | 0.150 |
Why?
| | Middle Aged | 15 | 2018 | 33479 | 0.150 |
Why?
| | Population | 1 | 2018 | 35 | 0.150 |
Why?
| | Case Management | 1 | 2018 | 66 | 0.150 |
Why?
| | Hypersensitivity | 2 | 2011 | 257 | 0.140 |
Why?
| | Health Policy | 1 | 2021 | 388 | 0.140 |
Why?
| | Qualitative Research | 2 | 2024 | 1386 | 0.140 |
Why?
| | Health Services Needs and Demand | 2 | 2011 | 273 | 0.140 |
Why?
| | Students | 2 | 2014 | 622 | 0.140 |
Why?
| | Practice Patterns, Physicians' | 4 | 2000 | 1313 | 0.140 |
Why?
| | Occupational Exposure | 2 | 2011 | 341 | 0.130 |
Why?
| | Pulmonary Medicine | 3 | 2024 | 85 | 0.130 |
Why?
| | Nursing Education Research | 1 | 2016 | 44 | 0.130 |
Why?
| | Aged | 11 | 2018 | 23961 | 0.130 |
Why?
| | Peripheral Arterial Disease | 1 | 2023 | 475 | 0.130 |
Why?
| | Biomarkers | 2 | 2024 | 4149 | 0.120 |
Why?
| | Education, Graduate | 1 | 2015 | 34 | 0.120 |
Why?
| | Patient Participation | 1 | 1999 | 420 | 0.120 |
Why?
| | Mass Screening | 1 | 2024 | 1287 | 0.120 |
Why?
| | Research Personnel | 2 | 2015 | 173 | 0.120 |
Why?
| | Urban Population | 1 | 2018 | 479 | 0.120 |
Why?
| | Information Dissemination | 2 | 2015 | 218 | 0.110 |
Why?
| | Health Education | 2 | 2009 | 341 | 0.110 |
Why?
| | Rural Population | 1 | 2018 | 563 | 0.110 |
Why?
| | Interviews as Topic | 3 | 2024 | 786 | 0.110 |
Why?
| | Epinephrine | 2 | 2011 | 139 | 0.110 |
Why?
| | Administration, Inhalation | 2 | 2015 | 688 | 0.110 |
Why?
| | Education, Continuing | 1 | 2014 | 39 | 0.110 |
Why?
| | Diabetes Complications | 1 | 2015 | 227 | 0.100 |
Why?
| | Hypertension | 1 | 2022 | 1295 | 0.100 |
Why?
| | Drug Utilization | 1 | 2013 | 169 | 0.100 |
Why?
| | Universities | 1 | 2015 | 433 | 0.100 |
Why?
| | Health Services Research | 1 | 2015 | 404 | 0.100 |
Why?
| | Severity of Illness Index | 4 | 2008 | 2828 | 0.100 |
Why?
| | Mentors | 3 | 2023 | 202 | 0.090 |
Why?
| | Activities of Daily Living | 2 | 2006 | 413 | 0.090 |
Why?
| | Healthcare Disparities | 1 | 2018 | 654 | 0.090 |
Why?
| | Motivation | 3 | 2007 | 570 | 0.090 |
Why?
| | General Surgery | 1 | 2013 | 173 | 0.090 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2015 | 279 | 0.090 |
Why?
| | Socioeconomic Factors | 2 | 2013 | 1289 | 0.090 |
Why?
| | Respiratory Function Tests | 3 | 2024 | 600 | 0.090 |
Why?
| | Medication Adherence | 1 | 2015 | 467 | 0.090 |
Why?
| | Quality Indicators, Health Care | 1 | 2014 | 307 | 0.090 |
Why?
| | Infant | 5 | 2024 | 9465 | 0.090 |
Why?
| | Risk Factors | 5 | 2023 | 10388 | 0.080 |
Why?
| | Fellowships and Scholarships | 1 | 2013 | 306 | 0.080 |
Why?
| | Internet | 2 | 2011 | 655 | 0.080 |
Why?
| | Health Services Administration | 1 | 2009 | 8 | 0.080 |
Why?
| | Health Promotion | 1 | 2016 | 741 | 0.080 |
Why?
| | Young Adult | 2 | 2018 | 13209 | 0.080 |
Why?
| | Reproducibility of Results | 3 | 2008 | 3284 | 0.080 |
Why?
| | Suction | 1 | 2009 | 34 | 0.080 |
Why?
| | Curriculum | 3 | 2015 | 992 | 0.070 |
Why?
| | Nursing Methodology Research | 2 | 2007 | 49 | 0.070 |
Why?
| | Demography | 1 | 2009 | 291 | 0.070 |
Why?
| | Age Factors | 2 | 2007 | 3295 | 0.070 |
Why?
| | Canada | 5 | 2011 | 418 | 0.070 |
Why?
| | Scientific Misconduct | 1 | 2008 | 12 | 0.070 |
Why?
| | Databases as Topic | 1 | 2007 | 67 | 0.070 |
Why?
| | Delivery of Health Care | 2 | 2022 | 951 | 0.070 |
Why?
| | Quality Control | 1 | 2008 | 172 | 0.070 |
Why?
| | Risk | 1 | 2010 | 912 | 0.070 |
Why?
| | Information Services | 1 | 2007 | 49 | 0.070 |
Why?
| | Food Hypersensitivity | 1 | 2010 | 183 | 0.070 |
Why?
| | Cross-Sectional Studies | 3 | 2009 | 5472 | 0.070 |
Why?
| | Feasibility Studies | 1 | 2011 | 956 | 0.070 |
Why?
| | Circadian Rhythm | 5 | 1992 | 468 | 0.070 |
Why?
| | Health Status Indicators | 1 | 2007 | 171 | 0.070 |
Why?
| | Informed Consent | 1 | 2007 | 175 | 0.060 |
Why?
| | Employee Performance Appraisal | 1 | 2005 | 6 | 0.060 |
Why?
| | Child Welfare | 1 | 2007 | 216 | 0.060 |
Why?
| | Family Practice | 2 | 2000 | 464 | 0.060 |
Why?
| | Seasons | 1 | 2008 | 547 | 0.060 |
Why?
| | Health Plan Implementation | 1 | 2006 | 142 | 0.060 |
Why?
| | Telephone | 1 | 2005 | 173 | 0.060 |
Why?
| | Counseling | 1 | 2007 | 391 | 0.050 |
Why?
| | Decision Making | 2 | 2011 | 900 | 0.050 |
Why?
| | Patient Admission | 1 | 2006 | 197 | 0.050 |
Why?
| | Leukotriene Antagonists | 1 | 2004 | 43 | 0.050 |
Why?
| | Health Surveys | 1 | 2006 | 514 | 0.050 |
Why?
| | Europe | 1 | 2024 | 414 | 0.050 |
Why?
| | Patient Care Team | 1 | 2008 | 631 | 0.050 |
Why?
| | Internship and Residency | 1 | 2013 | 1147 | 0.050 |
Why?
| | Financing, Organized | 1 | 2023 | 35 | 0.050 |
Why?
| | Adrenergic beta-Agonists | 1 | 2004 | 134 | 0.050 |
Why?
| | Atherectomy | 1 | 2023 | 37 | 0.050 |
Why?
| | Advisory Committees | 1 | 2024 | 219 | 0.050 |
Why?
| | Vascular Patency | 1 | 2023 | 106 | 0.050 |
Why?
| | Popliteal Artery | 1 | 2023 | 59 | 0.050 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2023 | 128 | 0.050 |
Why?
| | Coated Materials, Biocompatible | 1 | 2023 | 62 | 0.050 |
Why?
| | Theophylline | 4 | 1992 | 67 | 0.050 |
Why?
| | Parent-Child Relations | 1 | 2005 | 272 | 0.050 |
Why?
| | United States | 4 | 2023 | 14841 | 0.050 |
Why?
| | Treatment Outcome | 4 | 2023 | 10811 | 0.050 |
Why?
| | Faculty | 1 | 2023 | 147 | 0.050 |
Why?
| | Adaptation, Physiological | 1 | 2006 | 553 | 0.050 |
Why?
| | Focus Groups | 1 | 2004 | 522 | 0.050 |
Why?
| | Femoral Artery | 1 | 2023 | 179 | 0.050 |
Why?
| | Educational Status | 1 | 2004 | 470 | 0.050 |
Why?
| | Chronic Disease | 1 | 2007 | 1793 | 0.050 |
Why?
| | Obesity | 1 | 2015 | 2992 | 0.040 |
Why?
| | Spirometry | 2 | 2000 | 281 | 0.040 |
Why?
| | Risk Assessment | 2 | 2007 | 3457 | 0.040 |
Why?
| | Self Efficacy | 1 | 2004 | 396 | 0.040 |
Why?
| | Guideline Adherence | 2 | 2008 | 556 | 0.040 |
Why?
| | Physicians | 1 | 2009 | 910 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 1 | 2004 | 496 | 0.040 |
Why?
| | Patient Compliance | 1 | 2004 | 581 | 0.040 |
Why?
| | Peer Group | 2 | 2011 | 242 | 0.040 |
Why?
| | Cooperative Behavior | 2 | 2015 | 451 | 0.040 |
Why?
| | Time Factors | 3 | 2007 | 6828 | 0.040 |
Why?
| | Health Status | 1 | 2004 | 792 | 0.040 |
Why?
| | Follow-Up Studies | 1 | 2008 | 5131 | 0.040 |
Why?
| | Health Care Surveys | 1 | 2000 | 565 | 0.040 |
Why?
| | Critical Care | 1 | 2004 | 601 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2004 | 915 | 0.040 |
Why?
| | Physicians, Family | 1 | 2000 | 201 | 0.040 |
Why?
| | Poverty | 1 | 2022 | 521 | 0.040 |
Why?
| | Mental Health | 1 | 2004 | 726 | 0.040 |
Why?
| | Cohort Studies | 1 | 2008 | 5742 | 0.030 |
Why?
| | Phenotype | 1 | 2024 | 3196 | 0.030 |
Why?
| | Research Design | 1 | 2022 | 1139 | 0.030 |
Why?
| | Prospective Studies | 1 | 2007 | 7604 | 0.030 |
Why?
| | Models, Educational | 1 | 2015 | 93 | 0.030 |
Why?
| | Capacity Building | 1 | 2015 | 63 | 0.030 |
Why?
| | Data Collection | 2 | 2009 | 673 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2015 | 191 | 0.030 |
Why?
| | Research Support as Topic | 1 | 2015 | 119 | 0.030 |
Why?
| | Inflammation | 2 | 2004 | 2837 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2024 | 6079 | 0.020 |
Why?
| | Histamine | 1 | 1991 | 67 | 0.020 |
Why?
| | Art | 1 | 2010 | 11 | 0.020 |
Why?
| | Receptors, Adrenergic, beta | 1 | 1991 | 127 | 0.020 |
Why?
| | Public Policy | 1 | 2010 | 85 | 0.020 |
Why?
| | Psychology | 1 | 2010 | 85 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2023 | 15657 | 0.020 |
Why?
| | Longitudinal Studies | 2 | 2008 | 2844 | 0.020 |
Why?
| | Risk Management | 1 | 2010 | 93 | 0.020 |
Why?
| | Ethanolamines | 1 | 1989 | 17 | 0.020 |
Why?
| | Respiratory Tract Diseases | 1 | 1991 | 184 | 0.020 |
Why?
| | Adrenergic Agonists | 1 | 2008 | 5 | 0.020 |
Why?
| | Social Behavior | 1 | 2011 | 287 | 0.020 |
Why?
| | Forced Expiratory Volume | 4 | 1992 | 531 | 0.020 |
Why?
| | Morbidity | 1 | 2009 | 324 | 0.020 |
Why?
| | Hydrocortisone | 1 | 1991 | 322 | 0.020 |
Why?
| | Self Administration | 1 | 2008 | 123 | 0.020 |
Why?
| | Morale | 1 | 2007 | 5 | 0.020 |
Why?
| | Perception | 1 | 2010 | 359 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2009 | 363 | 0.020 |
Why?
| | Career Choice | 1 | 2009 | 219 | 0.020 |
Why?
| | Insurance, Health | 1 | 2009 | 283 | 0.020 |
Why?
| | Quality Improvement | 1 | 2015 | 1178 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2015 | 1208 | 0.020 |
Why?
| | Body Mass Index | 1 | 2015 | 2389 | 0.020 |
Why?
| | Forms and Records Control | 1 | 2006 | 23 | 0.020 |
Why?
| | Acute Disease | 1 | 2008 | 1007 | 0.020 |
Why?
| | Education | 1 | 2006 | 108 | 0.010 |
Why?
| | Emotions | 1 | 2010 | 548 | 0.010 |
Why?
| | Teaching | 1 | 2007 | 224 | 0.010 |
Why?
| | Age Distribution | 1 | 2006 | 392 | 0.010 |
Why?
| | Sex Distribution | 1 | 2006 | 375 | 0.010 |
Why?
| | Double-Blind Method | 2 | 2006 | 1993 | 0.010 |
Why?
| | Adrenal Cortex Hormones | 1 | 2008 | 565 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 1946 | 0.010 |
Why?
| | Respiration, Artificial | 1 | 2009 | 645 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 2008 | 740 | 0.010 |
Why?
| | Oxygen | 1 | 2009 | 931 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2008 | 594 | 0.010 |
Why?
| | Databases, Factual | 1 | 2009 | 1357 | 0.010 |
Why?
| | Pharmacies | 1 | 2004 | 38 | 0.010 |
Why?
| | Patient Selection | 1 | 2007 | 696 | 0.010 |
Why?
| | Decision Support Techniques | 1 | 2007 | 421 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2009 | 1477 | 0.010 |
Why?
| | Referral and Consultation | 1 | 2008 | 786 | 0.010 |
Why?
| | Drug Prescriptions | 1 | 2004 | 245 | 0.010 |
Why?
| | Peak Expiratory Flow Rate | 2 | 1992 | 37 | 0.010 |
Why?
| | Methacholine Chloride | 2 | 1992 | 52 | 0.010 |
Why?
| | Bronchial Provocation Tests | 2 | 1992 | 51 | 0.010 |
Why?
| | Patient Readmission | 1 | 2006 | 697 | 0.010 |
Why?
| | Health Behavior | 1 | 2005 | 762 | 0.010 |
Why?
| | Sleep Stages | 2 | 1989 | 47 | 0.010 |
Why?
| | Lung | 1 | 1992 | 4060 | 0.010 |
Why?
| | Communication | 1 | 2005 | 879 | 0.010 |
Why?
| | Random Allocation | 2 | 1989 | 353 | 0.010 |
Why?
| | Delayed-Action Preparations | 2 | 1989 | 181 | 0.010 |
Why?
| | Sleep | 2 | 1991 | 755 | 0.010 |
Why?
| | Pindolol | 1 | 1991 | 15 | 0.010 |
Why?
| | Radioligand Assay | 1 | 1991 | 48 | 0.010 |
Why?
| | Bronchoconstriction | 1 | 1991 | 32 | 0.010 |
Why?
| | Binding, Competitive | 1 | 1991 | 202 | 0.010 |
Why?
| | Isoproterenol | 1 | 1991 | 113 | 0.010 |
Why?
| | Cell Count | 1 | 1991 | 324 | 0.010 |
Why?
| | Methacholine Compounds | 1 | 1990 | 2 | 0.010 |
Why?
| | Leukocyte Count | 1 | 1991 | 329 | 0.010 |
Why?
| | Cyclic AMP | 1 | 1991 | 234 | 0.010 |
Why?
| | Bronchoscopy | 1 | 1991 | 223 | 0.000 |
Why?
| | Cell Separation | 1 | 1991 | 318 | 0.000 |
Why?
| | Leukocytes | 1 | 1991 | 311 | 0.000 |
Why?
| | Sodium Chloride | 1 | 1990 | 142 | 0.000 |
Why?
| | Drug Evaluation | 1 | 1989 | 84 | 0.000 |
Why?
| | Pulmonary Gas Exchange | 1 | 1989 | 121 | 0.000 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 1991 | 597 | 0.000 |
Why?
| | Bronchi | 1 | 1990 | 260 | 0.000 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 1991 | 652 | 0.000 |
Why?
| | Administration, Oral | 1 | 1989 | 816 | 0.000 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1989 | 2057 | 0.000 |
Why?
| | Clinical Trials as Topic | 1 | 1989 | 1050 | 0.000 |
Why?
|
|
Cicutto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|